Benufutamab | Interleukin Related interleukin-related.com

Product Name :
Benufutamab

Search keywords :
Benufutamab

drugId :
null

Target Vo:
Tumor necrosis factor receptor superfamily member 10B

Target Vo Short Name :
DR5

Moa_Name:
Tumor necrosis factor receptor superfamily member 10B agonists

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Idd Biotech

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Carcinoma, Non-Small-Cell Lung

Termination Status :
Phase 2 Clinical

China Termination Status :

Highest Status:
Discontinued

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Patritumab deruxtecan Biological Activity
Ligelizumab Protocol
Phospho-AMPK alpha 1 (Ser496) Antibody (YA226): Phospho-AMPK alpha 1 (Ser496) Antibody (YA226) is a non-conjugated and Rabbit origined monoclonal antibody about 64 kDa, targeting to Phospho-AMPK alpha 1 (S496). It can be used for WB,ICC/IF,IP assays with tag free, in the background of Human.

Author: Interleukin Related

Related Posts